Albertsons Faces Mixed Analyst Views After Price Target Adjustments
On January 8, 2026, BofA lowered Albertsons' price target to $20 and kept a Neutral rating, while Telsey Advisory cut its target to $22 but maintained an Outperform rating, citing Q3 performance driven by digital and pharmacy growth.